{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T10:49:45Z","timestamp":1790678985841,"version":"4.1.0"},"reference-count":48,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,1,1]],"date-time":"2018-01-01T00:00:00Z","timestamp":1514764800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Brain Research"],"published-print":{"date-parts":[[2018,1]]},"DOI":"10.1016\/j.brainres.2017.10.016","type":"journal-article","created":{"date-parts":[[2017,10,23]],"date-time":"2017-10-23T16:20:58Z","timestamp":1508775658000},"page":"116-122","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":38,"special_numbering":"C","title":["Brain metabolic correlates of CSF Tau protein in a large cohort of Alzheimer\u2019s disease patients: A CSF and FDG PET study"],"prefix":"10.1016","volume":"1678","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8017-8858","authenticated-orcid":false,"given":"Agostino","family":"Chiaravalloti","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gaetano","family":"Barbagallo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Ricci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandro","family":"Martorana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Ursini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pasqualina","family":"Sannino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Georgios","family":"Karalis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Orazio","family":"Schillaci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.brainres.2017.10.016_b0005","doi-asserted-by":"crossref","first-page":"1976","DOI":"10.1007\/s00415-014-7449-x","article-title":"Cerebellar metabolic involvement and its correlations with clinical parameters in vestibular neuritis","volume":"261","author":"Alessandrini","year":"2014","journal-title":"J. Neurol."},{"key":"10.1016\/j.brainres.2017.10.016_b0010","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1007\/s10548-015-0453-3","article-title":"Involvement of subcortical brain structures during olfactory stimulation in multiple chemical sensitivity","volume":"29","author":"Alessandrini","year":"2016","journal-title":"Brain Topogr."},{"key":"10.1016\/j.brainres.2017.10.016_b0015","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1016\/S0140-6736(10)61349-9","article-title":"Alzheimer\u2019s disease","volume":"377","author":"Ballard","year":"2011","journal-title":"Lancet"},{"key":"10.1016\/j.brainres.2017.10.016_b0020","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1007\/s00259-014-2961-x","article-title":"FDG PET\/CT: EANM procedure guidelines for tumour imaging: version 2.0","volume":"42","author":"Boellaard","year":"2015","journal-title":"Eur. J. Nucl. Med. Mol. Imaging"},{"key":"10.1016\/j.brainres.2017.10.016_b0025","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1007\/BF00308809","article-title":"Neuropathological stageing of Alzheimer-related changes","volume":"82","author":"Braak","year":"1991","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.brainres.2017.10.016_b0030","doi-asserted-by":"crossref","unstructured":"Brier, M.R., Gordon, B., Friedrichsen, K., McCarthy, J., Stern, A., Christensen, J., Owen, C., Aldea, P., Su, Y., Hassenstab, J., Cairns, N.J., Holtzman, D.M., Fagan, A.M., Morris, J.C., Benzinger, T.L., Ances, B.M., 2016. Tau and Abeta imaging, CSF measures, and cognition in Alzheimer's disease. Sci. Transl. Med. 8, 338ra66.","DOI":"10.1126\/scitranslmed.aaf2362"},{"key":"10.1016\/j.brainres.2017.10.016_b0035","doi-asserted-by":"crossref","first-page":"e82","DOI":"10.1093\/brain\/awm140","article-title":"No correlation between CSF tau protein phosphorylated at threonine 181 with neocortical neurofibrillary pathology in Alzheimer\u2019s disease","volume":"130","author":"Buerger","year":"2007","journal-title":"Brain"},{"key":"10.1016\/j.brainres.2017.10.016_b0040","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1007\/s100720200003","article-title":"Rey-Osterrieth complex figure: normative values in an Italian population sample","volume":"22","author":"Caffarra","year":"2002","journal-title":"Neurol. Sci."},{"key":"10.1016\/j.brainres.2017.10.016_b0045","doi-asserted-by":"crossref","first-page":"1557","DOI":"10.1001\/archneurol.2009.279","article-title":"Absence of Pittsburgh compound B detection of cerebral amyloid beta in a patient with clinical, cognitive, and cerebrospinal fluid markers of Alzheimer disease: a case report","volume":"66","author":"Cairns","year":"2009","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.brainres.2017.10.016_b0050","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1159\/000117297","article-title":"The mental deterioration battery: normative data, diagnostic reliability and qualitative analyses of cognitive impairment. The group for the standardization of the mental deterioration battery","volume":"36","author":"Carlesimo","year":"1996","journal-title":"Eur. Neurol."},{"key":"10.1016\/j.brainres.2017.10.016_b0055","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.brainresbull.2008.01.010","article-title":"CSF phosporylated TAU protein levels correlate with cerebral glucose metabolism assessed with PET in Alzheimer\u2019s disease","volume":"76","author":"Ceravolo","year":"2008","journal-title":"Brain Res. Bull."},{"key":"10.1016\/j.brainres.2017.10.016_b0060","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1007\/s00259-014-2969-2","article-title":"Cortical activity during olfactory stimulation in multiple chemical sensitivity: a (18)F-FDG PET\/CT study","volume":"42","author":"Chiaravalloti","year":"2015","journal-title":"Eur. J. Nucl. Med. Mol. Imaging"},{"key":"10.1016\/j.brainres.2017.10.016_b0065","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1097\/MNM.0000000000000272","article-title":"Functional correlates of t-Tau, p-Tau and Abeta(1)(-)(4)(2) amyloid cerebrospinal fluid levels in Alzheimer\u2019s disease: a (1)(8)F-FDG PET\/CT study","volume":"36","author":"Chiaravalloti","year":"2015","journal-title":"Nucl. Med. Commun."},{"key":"10.1016\/j.brainres.2017.10.016_b0070","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1159\/000441776","article-title":"Comparison between early-onset and late-onset Alzheimer\u2019s disease patients with amnestic presentation: CSF and (18)F-FDG PET study","volume":"6","author":"Chiaravalloti","year":"2016","journal-title":"Dement Geriatr. Cogn. Dis. Extra"},{"key":"10.1016\/j.brainres.2017.10.016_b0075","doi-asserted-by":"crossref","DOI":"10.1038\/mp.2017.108","article-title":"Longitudinal changes of tau PET imaging in relation to hypometabolism in prodromal and Alzheimer's disease dementia","author":"Chiotis","year":"2017","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.brainres.2017.10.016_b0080","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1097\/WAD.0b013e31821300bc","article-title":"Correlation of amyloid PET ligand florbetapir F 18 binding with Abeta aggregation and neuritic plaque deposition in postmortem brain tissue","volume":"26","author":"Choi","year":"2012","journal-title":"Alzheimer Dis. Assoc. Disord."},{"key":"10.1016\/j.brainres.2017.10.016_b0085","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1007\/s00401-014-1349-0","article-title":"Primary age-related tauopathy (PART): a common pathology associated with human aging","volume":"128","author":"Crary","year":"2014","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.brainres.2017.10.016_b0090","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/j.neuroimage.2014.10.050","article-title":"The mediational effects of FDG hypometabolism on the association between cerebrospinal fluid biomarkers and neurocognitive function","volume":"105","author":"Dowling","year":"2015","journal-title":"Neuroimage"},{"key":"10.1016\/j.brainres.2017.10.016_b0095","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1016\/S1474-4422(14)70090-0","article-title":"Advancing research diagnostic criteria for Alzheimer\u2019s disease: the IWG-2 criteria","volume":"13","author":"Dubois","year":"2014","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.brainres.2017.10.016_b0100","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1002\/emmm.200900048","article-title":"Cerebrospinal fluid tau and ptau(181) increase with cortical amyloid deposition in cognitively normal individuals: Implications for future clinical trials of Alzheimer\u2019s disease","volume":"1","author":"Fagan","year":"2009","journal-title":"EMBO Mol. Med."},{"key":"10.1016\/j.brainres.2017.10.016_b0105","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1161\/STROKEAHA.108.530337","article-title":"Interhemispheric distribution of Alzheimer disease and vascular pathology in brain aging","volume":"40","author":"Giannakopoulos","year":"2009","journal-title":"Stroke"},{"key":"10.1016\/j.brainres.2017.10.016_b0110","doi-asserted-by":"crossref","first-page":"2249","DOI":"10.1093\/brain\/aww139","article-title":"The relationship between cerebrospinal fluid markers of Alzheimer pathology and positron emission tomography tau imaging","volume":"139","author":"Gordon","year":"2016","journal-title":"Brain"},{"key":"10.1016\/j.brainres.2017.10.016_b0115","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1111\/j.1468-1331.2008.02274.x","article-title":"CSF total and phosphorylated tau protein, regional glucose metabolism and dementia severity in Alzheimer's disease","volume":"15","author":"Haense","year":"2008","journal-title":"Eur. J. Neurol."},{"key":"10.1016\/j.brainres.2017.10.016_b0120","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1002\/ana.24910","article-title":"Fluorodeoxyglucose metabolism associated with tau-amyloid interaction predicts memory decline","volume":"81","author":"Hanseeuw","year":"2017","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.brainres.2017.10.016_b0125","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/j.jalz.2016.09.009","article-title":"Recommendations for cerebrospinal fluid Alzheimer's disease biomarkers in the diagnostic evaluation of mild cognitive impairment","volume":"13","author":"Herukka","year":"2017","journal-title":"Alzheimers Dement."},{"key":"10.1016\/j.brainres.2017.10.016_b0130","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/j.jalz.2016.08.005","article-title":"Defining imaging biomarker cut points for brain aging and Alzheimer's disease","volume":"13","author":"Jack","year":"2017","journal-title":"Alzheimers Dement."},{"key":"10.1016\/j.brainres.2017.10.016_b0135","doi-asserted-by":"crossref","first-page":"817","DOI":"10.3233\/JAD-150238","article-title":"Alzheimer's disease cerebrospinal fluid and neuroimaging biomarkers: diagnostic accuracy and relationship to drug efficacy","volume":"46","author":"Khan","year":"2015","journal-title":"J. Alzheimers Dis."},{"key":"10.1016\/j.brainres.2017.10.016_b0140","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1002\/(SICI)1097-0193(1997)5:4<238::AID-HBM6>3.0.CO;2-4","article-title":"Automated labeling of the human brain: a preliminary report on the development and evaluation of a forward-transform method","volume":"5","author":"Lancaster","year":"1997","journal-title":"Hum Brain Mapp."},{"key":"10.1016\/j.brainres.2017.10.016_b0145","doi-asserted-by":"crossref","first-page":"2040","DOI":"10.1007\/s00259-016-3417-2","article-title":"Cerebrospinal fluid lactate levels and brain [18F]FDG PET hypometabolism within the default mode network in Alzheimer's disease","volume":"43","author":"Liguori","year":"2016","journal-title":"Eur. J. Nucl. Med. Mol. Imaging"},{"key":"10.1016\/j.brainres.2017.10.016_b0150","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1017\/S1041610296002529","article-title":"The mini-mental state examination in Alzheimer's disease and multi-infarct dementia","volume":"8","author":"Magni","year":"1996","journal-title":"Int. Psychogeriatr."},{"key":"10.1016\/j.brainres.2017.10.016_b0155","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1002\/acn3.81","article-title":"Diagnostic accuracy of CSF Ab42 and florbetapir PET for Alzheimer's disease","volume":"1","author":"Mattsson","year":"2014","journal-title":"Ann. Clin. Transl. Neurol."},{"key":"10.1016\/j.brainres.2017.10.016_b0160","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.dadm.2017.02.004","article-title":"A multinational study distinguishing Alzheimer's and healthy patients using cerebrospinal fluid tau\/Abeta42 cutoff with concordance to amyloid positron emission tomography imaging","volume":"6","author":"Mo","year":"2017","journal-title":"Alzheimers Dement. (Amst)"},{"key":"10.1016\/j.brainres.2017.10.016_b0165","doi-asserted-by":"crossref","first-page":"1551","DOI":"10.1093\/brain\/aww027","article-title":"Tau PET patterns mirror clinical and neuroanatomical variability in Alzheimer's disease","volume":"139","author":"Ossenkoppele","year":"2016","journal-title":"Brain"},{"key":"10.1016\/j.brainres.2017.10.016_b0170","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.nicl.2014.11.007","article-title":"Volume of interest-based [18F]fluorodeoxyglucose PET discriminates MCI converting to Alzheimer's disease from healthy controls. A European Alzheimer's Disease Consortium (EADC) study","volume":"7","author":"Pagani","year":"2015","journal-title":"Neuroimage Clin."},{"key":"10.1016\/j.brainres.2017.10.016_b0175","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1001\/archneurol.2009.59","article-title":"Preclinical evidence of Alzheimer changes: convergent cerebrospinal fluid biomarker and fluorodeoxyglucose positron emission tomography findings","volume":"66","author":"Petrie","year":"2009","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.brainres.2017.10.016_b0180","doi-asserted-by":"crossref","first-page":"2410","DOI":"10.1016\/j.clinph.2004.04.022","article-title":"Different TMS patterns of intracortical inhibition in early onset Alzheimer dementia and frontotemporal dementia","volume":"115","author":"Pierantozzi","year":"2004","journal-title":"Clin. Neurophysiol."},{"key":"10.1016\/j.brainres.2017.10.016_b0185","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1001\/jamaneurol.2016.5953","article-title":"Neurofibrillary tangle stage and the rate of progression of alzheimer symptoms: modeling using an autopsy cohort and application to clinical trial design","volume":"74","author":"Qian","year":"2017","journal-title":"JAMA Neurol."},{"key":"10.1016\/j.brainres.2017.10.016_b0190","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1162\/089892900561814","article-title":"Age differences in the frontal lateralization of verbal and spatial working memory revealed by PET","volume":"12","author":"Reuter-Lorenz","year":"2000","journal-title":"J. Cogn. Neurosci."},{"key":"10.1016\/j.brainres.2017.10.016_b0195","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1186\/s13195-016-0204-z","article-title":"Regional tau deposition measured by [18F]THK5317 positron emission tomography is associated to cognition via glucose metabolism in Alzheimer's disease","volume":"8","author":"Saint-Aubert","year":"2016","journal-title":"Alzheimers Res. Ther."},{"key":"10.1016\/j.brainres.2017.10.016_b0200","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1016\/j.expneurol.2009.07.028","article-title":"Abeta1-42 detection in CSF of Alzheimer's disease is influenced by temperature: indication of reversible Abeta1-42 aggregation?","volume":"223","author":"Sancesario","year":"2010","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.brainres.2017.10.016_b0205","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1016\/j.neuron.2016.01.028","article-title":"PET imaging of tau deposition in the aging human brain","volume":"89","author":"Scholl","year":"2016","journal-title":"Neuron"},{"key":"10.1016\/j.brainres.2017.10.016_b0210","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1093\/brain\/aww023","article-title":"Regional profiles of the candidate tau PET ligand 18F-AV-1451 recapitulate key features of Braak histopathological stages","volume":"139","author":"Schwarz","year":"2016","journal-title":"Brain"},{"key":"10.1016\/j.brainres.2017.10.016_b0215","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1038\/nprot.2006.115","article-title":"Clinical and empirical applications of the Rey-Osterrieth complex figure test","volume":"1","author":"Shin","year":"2006","journal-title":"Nat. Protoc."},{"key":"10.1016\/j.brainres.2017.10.016_b0220","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1006\/nimg.2002.1259","article-title":"Statistical parametric mapping of (99m)Tc-HMPAO-SPECT images for the diagnosis of Alzheimer's disease: normalizing to cerebellar tracer uptake","volume":"17","author":"Soonawala","year":"2002","journal-title":"Neuroimage"},{"key":"10.1016\/j.brainres.2017.10.016_b0225","doi-asserted-by":"crossref","DOI":"10.1093\/brain\/awx046","article-title":"Association between tau deposition and antecedent amyloid-beta accumulation rates in normal and early symptomatic individuals","author":"Tosun","year":"2017","journal-title":"Brain"},{"key":"10.1016\/j.brainres.2017.10.016_b0230","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.1001\/jamaneurol.2016.2078","article-title":"Evaluation of tau imaging in staging Alzheimer disease and revealing interactions between beta-amyloid and tauopathy","volume":"73","author":"Wang","year":"2016","journal-title":"JAMA Neurol."},{"key":"10.1016\/j.brainres.2017.10.016_b0235","doi-asserted-by":"crossref","first-page":"241","DOI":"10.2174\/156720512799361592","article-title":"Stage-dependent agreement between cerebrospinal fluid proteins and FDG-PET findings in Alzheimer's disease","volume":"9","author":"Yakushev","year":"2012","journal-title":"Curr. Alzheimer Res."},{"key":"10.1016\/j.brainres.2017.10.016_b0240","doi-asserted-by":"crossref","first-page":"801","DOI":"10.3233\/JAD-132561","article-title":"Concordance between cerebrospinal fluid biomarkers and [11C]PIB PET in a memory clinic cohort","volume":"41","author":"Zwan","year":"2014","journal-title":"J. Alzheimers Dis."}],"container-title":["Brain Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006899317304742?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006899317304742?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,8,5]],"date-time":"2022-08-05T01:31:54Z","timestamp":1659663114000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006899317304742"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,1]]},"references-count":48,"alternative-id":["S0006899317304742"],"URL":"https:\/\/doi.org\/10.1016\/j.brainres.2017.10.016","relation":{},"ISSN":["0006-8993"],"issn-type":[{"value":"0006-8993","type":"print"}],"subject":[],"published":{"date-parts":[[2018,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Brain metabolic correlates of CSF Tau protein in a large cohort of Alzheimer\u2019s disease patients: A CSF and FDG PET study","name":"articletitle","label":"Article Title"},{"value":"Brain Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.brainres.2017.10.016","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}